Further supporting this combined approach, a secondary analysis of a randomized clinical trial involving adults with obesity found that the combination of exercise and GLP-1 therapy preserved BMD at the hip, spine, and forearm, despite greater total weight loss (Jensen et al., 2024). The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.